Wealth Alliance’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,655	Closed	-$249K	–	546
2025 Q1	$249K	Sell	1,655 -67	-4%	-$11.2K	0.03%	441
2024 Q4	$318K	Sell	1,722 -183	-10%	-$35.3K	0.04%	368
2024 Q3	$375K	Buy	1,905 +37	+2%	+$7.69K	0.04%	342
2024 Q2	$386K	Buy	1,868 +10	+0.5%	+$2.27K	0.05%	313
2024 Q1	$503K	Buy	1,858 +6	+0.3%	+$1.43K	0.07%	270
2023 Q4	$438K	Sell	1,852 -22	-1%	-$4.33K	0.06%	283
2023 Q3	$367K	Sell	1,874 -49	-3%	-$10.1K	0.06%	296
2023 Q2	$404K	Buy	1,923 +235	+14%	+$46.8K	0.06%	292
2023 Q1	$341K	Sell	1,688 -82	-5%	-$18.6K	0.06%	323
2022 Q4	$386K	Buy	1,770 +353	+25%	+$77.1K	0.07%	282
2022 Q3	$279K	Sell	1,417 -252	-15%	-$54.4K	0.06%	338
2022 Q2	$358K	Buy	1,669 +75	+5%	+$18.3K	0.07%	280
2022 Q1	$453K	Buy	1,594 +29	+2%	+$8.94K	0.09%	237
2021 Q4	$590K	Sell	1,565 -59	-4%	-$22.9K	0.12%	195
2021 Q3	$670K	Sell	1,624 -24	-1%	-$9.97K	0.15%	154
2021 Q2	$610K	Buy	1,648 +112	+7%	+$37.4K	0.14%	167
2021 Q1	$445K	Buy	1,536 +85	+6%	+$23.6K	0.12%	193
2020 Q4	$363K	Sell	1,451 -242	-14%	-$57.6K	0.11%	233
2020 Q3	$383K	Buy	1,693 +30	+2%	+$6.23K	0.14%	179
2020 Q2	$290K	Buy	+1,663	New	+$265K	0.11%	227